Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P13
Within normal range
vs 5Y Ago
-16.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -26.69% |
| Q2 2025 | 23.75% |
| Q1 2025 | 4.19% |
| Q4 2024 | 6.08% |
| Q3 2024 | -20.05% |
| Q2 2024 | 3.05% |
| Q1 2024 | 9.10% |
| Q4 2023 | 40.49% |
| Q3 2023 | -22.36% |
| Q2 2023 | 5.20% |
| Q1 2023 | -7.55% |
| Q4 2022 | 12.22% |
| Q3 2022 | -10.41% |
| Q2 2022 | 2.33% |
| Q1 2022 | 16.36% |
| Q4 2021 | -15.55% |
| Q3 2021 | 21.52% |
| Q2 2021 | 66.51% |
| Q1 2021 | 15.76% |
| Q4 2020 | 14.02% |
| Q3 2020 | 1.66% |
| Q2 2020 | -10.34% |
| Q1 2020 | -71.52% |
| Q4 2019 | 0.86% |
| Q3 2019 | 6.32% |
| Q2 2019 | -6.15% |
| Q1 2019 | 217.17% |
| Q4 2018 | -66.38% |
| Q3 2018 | 57.88% |
| Q2 2018 | -37.38% |
| Q1 2018 | -12.16% |
| Q4 2017 | -4.89% |
| Q3 2017 | -52.97% |
| Q2 2017 | 50.81% |
| Q1 2017 | -34.88% |
| Q4 2016 | -13.20% |
| Q3 2016 | 12.51% |
| Q2 2016 | -22.44% |
| Q1 2016 | -0.81% |
| Q4 2015 | 12.88% |